U.S. FDA Expands Indication for Impella Heart Pumps to Treat Pediatric Patients
Press Releases
Johnson & Johnson MedTech  
December 12, 2024

U.S. FDA Expands Indication for Impella Heart Pumps to Treat Pediatric Patients

Impella 5.5 and Impella CP are the first left-sided, minimally invasive temporary mechanical circulatory support options for pediatric patients with symptomatic ADHF and cardiogenic shock

logo salamanca press

Salamanca Press

Local & Social